🇺🇸 FDA
Patent

US 10772972

Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof

granted A61KA61K2039/505A61K47/68033

Quick answer

US patent 10772972 (Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K2039/505, A61K47/68033, A61K47/6869, A61K47/6871